CoChat

European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making

Open access
Andratschke, Nicolaus, Willmann, Jonas, Appelt, Ane L, Alyamani, Najlaa, Balermpas, Panagiotis, Baumert, Brigitta G, Hurkmans, Coen, Høyer, Morten, Langendijk, Johannes A, Kaidar-Person, Orit, van der Linden, Yvette, Meattini, Icro, Niyazi, Maximilian, Reynaert, Nick, De Ruysscher, Dirk, Tanadini-Lang, Stephanie, Hoskin, Peter, Poortmans, Philip, Nieder, Carsten · 2022 · The Lancet Oncology
Cited by 215

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Re-irradiation can be considered for local recurrence or new tumours adjacent to a previously irradiated site to achieve durable local control for patients with cancer who have otherwise few therapeutic options. With the use of new radiotherapy techniques, which allow for conformal treatment plans, image guidance, and short fractionation schemes, the use of re-irradiation for different sites is increasing in clinical settings. Yet, prospective evidence on re-irradiation is scarce and our understanding of the underlying radiobiology is poor. Our consensus on re-irradiation aims to assist in re-irradiation decision making, and to standardise the classification of different forms of re-irradiation and reporting. The consensus has been endorsed by the European Society for Radiotherapy and Oncology and the European Organisation for Research and Treatment of Cancer. The use of this classification in daily clinical practice and research will facilitate accurate understanding of the clinical implications of re-irradiation and allow for cross-study comparisons. Data gathered in a uniform manner could be used in the future to make recommendations for re-irradiation on the basis of clinical evidence. The consensus document is based on an adapted Delphi process and a systematic review of the literature was done according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1470-2045(22)00447-8

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Metadata

Authors
Andratschke, N., Willmann, J., Appelt, A. L., Alyamani, N., Balermpas, P., Baumert, B. G., Hurkmans, C., Høyer, M., Langendijk, J. A., Kaidar-Person, O., van der Linden, Y., Meattini, I., Niyazi, M., Reynaert, N., De Ruysscher, D., Tanadini-Lang, S., Hoskin, P., Poortmans, P., & Nieder, C.
Venue
The Lancet Oncology
Publisher
Elsevier BV
Published
2022-10
Volume
23
Issue
10
Pages
e469-e478
ISSN
1470-2045 (ISSN-L)
OpenAlex
W4297102192
Cited by
215
References
4
FWCI
25.55
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. https://app.cochat.ai/papers/10.1016/s1470-2045(22)00447-8
The paper
Andratschke, N., Willmann, J., Appelt, A. L., Alyamani, N., Balermpas, P., Baumert, B. G., Hurkmans, C., Høyer, M., Langendijk, J. A., Kaidar-Person, O., van der Linden, Y., Meattini, I., Niyazi, M., Reynaert, N., De Ruysscher, D., Tanadini-Lang, S., Hoskin, P., Poortmans, P., & Nieder, C. (2022). European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(22)00447-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.